To learn more about how to engage our services for industry-sponsored or investigator-initiated multicenter studies, establish strategic relationships, or to discuss how CTX might support your grant proposal for multi-institutional research​.

UT System Named as​ Parexel Strategic Site Alliance

April 26, 2018 | Houston Texas


New CTX - PAREXEL Alliance accelerates development of novel therapeutics to benefit patients.


Clinical Trials Xpress (CTX), an initiative of the University of Texas System, has been named by PAREXEL, the world's leading innovator of biopharmaceutical services, as a member of its Global Site Alliance Network. Through the network, CTX will work with PAREXEL to further clinical development of novel drug therapies through the facilitation of research.

OUR INITIATIVE

Clinical Trials Xpress (CTX) is a UT System initiative launched in 2015 with support and seed funding from its Board of Regents, CTX represents an unmatched resource to support multisite clinical and translational research in Texas. 



READ MORE

OUR MODEL

CONTACT US

A single point-of-entry for industry sponsors and physician investigators to access streamlined, efficient administrative processes, dedicated central office resources and accelerated activation timelines to conduct their multi-site clinical trials in Texas.


READ MORE

NEWS AND EVENTS